Filing Flows › Arrowhead Pharmaceuticals (ARWR) › Net income
Arrowhead Pharmaceuticals (ARWR) net income by quarter
Arrowhead Pharmaceuticals' net income was $30.8M in Q1 FY26 (first quarter fiscal 2026), +91% from Q4 FY25. Over the last 3 quarters it ranged from $16.1M (Q4 FY25) to $370M (Q2 FY25).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY26 | $30.8M | +91% | — |
| Q4 FY25 | $16.1M | -96% | — |
| Q2 FY25 | $370M | — | — |
Q1 FY26 at a glance
Arrowhead Pharmaceuticals, Q1 FY26: revenue $264M (106× year over year), operating margin 15.5%, net earnings $30.8M, operating cash flow $13.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arrowhead Pharmaceuticals' net income?
Arrowhead Pharmaceuticals' net income was $30.8M in Q1 FY26 (first quarter fiscal 2026), +91% from Q4 FY25.
How has Arrowhead Pharmaceuticals' net income changed?
Over the last 3 quarters it ranged from $16.1M (Q4 FY25) to $370M (Q2 FY25).
Q1 FY26 results → · How Arrowhead Pharmaceuticals makes money →